Package-Ref™ Cervix Cancer for Methylation control
CBPE0120-0122
询 价
索取COA
产品描述
产品数据库
| Introduction | ||
| Description | DNA methylation is an epigenetic modification, a form of chemical modification of DNA, which refers to the carbon 5 of cytosine in the genomic CpG dinucleotide under the action of DNA methyltransferase. covalently bonded to a methyl group. It can change genetic expression without changing the DNA sequence. This package contains multiple detection samples for Cervix cancer, We use simulated clinical cell lines to prepare them. If you are testing unknown genes and unknown regions, you can choose this product. |
|
| Technical Data | ||
| Cat No. | Name | Unit Size |
| CBPE0120 | Package-Ref™ Cervix Cancer for Methylation control-Small (10 Samples) | 500ng/ vial*10 vials |
| CBPE0121 | Package-Ref™ Cervix Cancer for Methylation control-Medium (20 Samples) | 500ng/ vial*20 vials |
| CBPE0122 | Package-Ref™ Cervix Cancer for Methylation control-Large (30 Samples) | 500ng/ vial*30 vials |
| Product Information | ||
| Intended Use | Research Use Only | |
| Concentration | Download for COA | |
| Purity | Download for COA | |
| DNA electrophoresis | Download for COA | |
| Format | Genomic DNA | |
| Storage | 2-8°C | |
| Expiry | 36 months from the date of manufacture | |
| Remark | The data in the instruction manual is the data of a single test, and the specific data of each batch is subject to delivery. | |
